Combined outcome of non‐fatal myocardial infarction, non‐fatal stroke, and total number of deaths · patients with acute coronary syndrome
Statins showed no clear difference in combined outcome of non‐fatal myocardial infarction, non‐fatal… compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Death from all causes · patients with acute coronary syndrome
Statins showed no clear difference in death from all causes compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Fatal & Nonfatal myocardial infarction or reinfarction · patients with acute coronary syndrome
Statins showed no clear difference in fatal and non‐fatal myocardial infarction or reinfarction compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Fatal or nonfatal stroke · patients with acute coronary syndrome
Statins showed no clear difference in fatal and non‐fatal stroke compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Unstable angina · patients with acute coronary syndrome
Statins probably leads to lower unstable angina compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Acute Heart Failure · patients with acute coronary syndrome
Statins showed no clear difference in acute heart failure compared with control at 4 months (3 to 6 months) (moderate certainty).
1 finding from 1 review
Rhabdomyolysis · patients with acute coronary syndrome
Statins showed no clear difference in rhabdomyolysis compared with control at 4 months (3 to 6 months) (low certainty).
1 finding from 1 review